Literature DB >> 6093608

Exogenous vasopressin reverses hyperactivity in the hypothalamus of Brattleboro rats.

T L Krukoff, F R Calaresu.   

Abstract

We have previously described an increase of cytochrome oxidase (COX) activity in discrete hypothalamic nuclei of the Brattleboro rat (BR). The present experiments were done to investigate whether this increase in COX activity could be eliminated by administration of exogenous arginine vasopressin (AVP). Continuous infusion of AVP to BR for 7 days corrected the polyuria and the urine hypoosmolality, as expected, and it also eliminated the COX hyperactivity in the paraventricular nucleus and nucleus circularis of the BR hypothalamus. These results suggest that the hyperactivity of these nuclei in the BR is directly related to their inability to produce AVP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093608     DOI: 10.1152/ajpregu.1984.247.5.R932

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.

Authors:  Wei Li; Yan Zhang; Richard Bouley; Ying Chen; Toshiyuki Matsuzaki; Paula Nunes; Udo Hasler; Dennis Brown; Hua A Jenny Lu
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Radioautographic study of glycoprotein synthesis and fate in the hypothalamo-neurohypophyseal system of vasopressin-deficient Brattleboro rats.

Authors:  A Haddad; G Pelletier
Journal:  Anat Embryol (Berl)       Date:  1987

3.  Manganese promotes intracellular accumulation of AQP2 via modulating F-actin polymerization and reduces urinary concentration in mice.

Authors:  Lei Lei; Ming Huang; Limin Su; Dongping Xie; Fahmy A Mamuya; Onju Ham; Kenji Tsuji; Teodor G Păunescu; Baoxue Yang; Hua A Jenny Lu
Journal:  Am J Physiol Renal Physiol       Date:  2017-10-18

Review 4.  A novel therapeutic effect of statins on nephrogenic diabetes insipidus.

Authors:  Leonilde Bonfrate; Giuseppe Procino; David Q-H Wang; Maria Svelto; Piero Portincasa
Journal:  J Cell Mol Med       Date:  2015-01-16       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.